Thalia Therapeutics Plc (AIM:THAT)
London · Delayed Price · Currency is GBP · Price in GBX 0.6710
-0.0290 (-4.14%)
Jul 24, 2026, 12:45 PM GMT
Thalia Therapeutics Revenue
In the year 2025, Thalia Therapeutics had annual revenue of 7.26M GBP, down -0.25%. Thalia Therapeutics had revenue of 7.26M in the half year ending December 31, 2025, with 271.75% growth.
Revenue (ttm)
7.26K
Revenue Growth
-0.25%
P/S Ratio
802.03
Revenue / Employee
2.42K
Employees
4
Market Cap
5.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.26M | -18.00K | -0.25% |
| Dec 31, 2024 | 7.28M | 7.28M | 372,762.26% |
| Dec 31, 2023 | 1.95K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | 1.16M | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | 2.26M | -417.00K | -15.57% |
| Dec 31, 2012 | 2.68M | -292.00K | -9.83% |
| Dec 31, 2011 | 2.97M | 1.05M | 54.77% |
| Dec 31, 2010 | 1.92M | 52.00K | 2.79% |
| Dec 31, 2009 | 1.87M | -110.00K | -5.56% |
| Dec 31, 2008 | 1.98M | 413.00K | 26.41% |
| Dec 31, 2007 | 1.56M | 166.00K | 11.87% |
| Dec 31, 2006 | 1.40M | 324.00K | 30.17% |
| Dec 31, 2005 | 1.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 9.76M |
| Futura Medical | 1.70M |
| Fusion Antibodies | 1.60M |
| Oxford BioDynamics | 1.20M |
| OptiBiotix Health | 1.17M |
| Physiomics | 1.01M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 231.00K |